Business Description
Veracyte Inc
NAICS : 541380
SIC : 8734
ISIN : US92337F1075
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.9 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.32 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 11.84 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.1 | |||||
3-Year EBITDA Growth Rate | -10.6 | |||||
3-Year EPS without NRI Growth Rate | 44 | |||||
3-Year Book Growth Rate | 25.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 10.94 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.88 | |||||
9-Day RSI | 63.07 | |||||
14-Day RSI | 57.5 | |||||
6-1 Month Momentum % | -4 | |||||
12-1 Month Momentum % | -11.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5 | |||||
Quick Ratio | 4.69 | |||||
Cash Ratio | 3.6 | |||||
Days Inventory | 46.48 | |||||
Days Sales Outstanding | 41.64 | |||||
Days Payable | 40.89 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8 | |||||
Shareholder Yield % | 0.11 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.54 | |||||
Operating Margin % | -3.32 | |||||
Net Margin % | -18.16 | |||||
FCF Margin % | 7.04 | |||||
ROE % | -6.34 | |||||
ROA % | -5.92 | |||||
ROIC % | -1.3 | |||||
ROC (Joel Greenblatt) % | -140.83 | |||||
ROCE % | -6.44 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.17 | |||||
PB Ratio | 1.46 | |||||
Price-to-Tangible-Book | 6.82 | |||||
Price-to-Free-Cash-Flow | 58.39 | |||||
Price-to-Operating-Cash-Flow | 41.25 | |||||
EV-to-EBIT | -21.68 | |||||
EV-to-EBITDA | -34.44 | |||||
EV-to-Revenue | 4.06 | |||||
EV-to-FCF | 54.64 | |||||
Price-to-Projected-FCF | 2.11 | |||||
Price-to-Median-PS-Value | 0.77 | |||||
Price-to-Net-Current-Asset-Value | 8.11 | |||||
Price-to-Net-Cash | 13.31 | |||||
Earnings Yield (Greenblatt) % | -4.61 | |||||
FCF Yield % | 1.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Veracyte Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 346.942 | ||
EPS (TTM) (€) | -0.871 | ||
Beta | 2.03 | ||
Volatility % | 41.39 | ||
14-Day RSI | 57.5 | ||
14-Day ATR (€) | 0.3876 | ||
20-Day SMA (€) | 18.485 | ||
12-1 Month Momentum % | -11.11 | ||
52-Week Range (€) | 17.5 - 26.6 | ||
Shares Outstanding (Mil) | 76.45 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Veracyte Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Veracyte Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Veracyte Inc Frequently Asked Questions
What is Veracyte Inc(FRA:12V)'s stock price today?
When is next earnings date of Veracyte Inc(FRA:12V)?
Does Veracyte Inc(FRA:12V) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |